Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-002388
Filing Date
2025-01-23
Accepted
2025-01-23 16:33:53
Documents
1
Period of Report
2025-01-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1737668026.html 4  
1 FORM 4 wk-form4_1737668026.xml 4 5128
  Complete submission text file 0001628280-25-002388.txt   6636
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001356576 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address
Hudson Frederick M. (Reporting) CIK: 0001438462 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35518 | Film No.: 25550583